journal
Journals Best Practice & Research. Clin...

Best Practice & Research. Clinical Rheumatology

https://read.qxmd.com/read/38008661/impact-of-sex-and-gender-on-axspa-diagnosis-and-outcomes
#21
REVIEW
Samantha O Kohn, Abeera Azam, Lauren E Hamilton, Stephanie R Harrison, Elizabeth R Graef, Kristen J Young, Helena Marzo-Ortega, Jean W Liew
Axial spondyloarthritis (axSpA) was historically considered a disease of men, largely due to the recognition of a more severe, progressive phenotype, ankylosing spondylitis (AS; or radiographic axSpA, r-axSpA) aiding the clinical diagnosis [1,2]. Data demonstrating the near equal prevalence of axSpA in women only started to emerge in the last decades, highlighting intrinsic differences in disease phenotype, and clinical and imaging characteristics between sexes, which partly explain the issue of underdiagnosis in women...
September 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37953121/magnetic-resonance-imaging-in-spondyloarthritis-friend-or-foe
#22
REVIEW
Manouk de Hooge, Torsten Diekhoff, Denis Poddubnyy
Magnetic resonance imaging (MRI) has emerged as a valuable tool for early detection and of axial spondyloarthritis (axSpA). A standardized imaging acquisition protocol, aligned with the current state-of-the-art, is crucial to obtain MRI scans that meet the diagnostic quality requirements. It is important to note that certain lesions, particularly bone marrow edema (BME), can be induced by mechanical stress or be a manifestation of another non-inflammatory disorder and may mimic the characteristic findings of axSpA on MRI...
September 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37659890/the-role-of-imaging-in-osteoarthritis
#23
REVIEW
Eun Hae Park, Jan Fritz
Osteoarthritis is a complex whole-organ disorder that involves molecular, anatomic, and physiologic derangement. Advances in imaging techniques have expanded the role of imaging in evaluating osteoarthritis and functional changes. Radiography, magnetic resonance imaging, computed tomography (CT), and ultrasonography are commonly used imaging modalities, each with advantages and limitations in evaluating osteoarthritis. Radiography comprehensively analyses alignment and osseous features, while MRI provides detailed information about cartilage damage, bone marrow edema, synovitis, and soft tissue abnormalities...
August 31, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37658017/to-taper-or-not-to-taper-biological-disease-modifying-antirheumatic-drugs-in-axial-spondyloarthritis-anno-2023-that-is-the-question
#24
REVIEW
Zuzanna Lukasik, Philippe Carron, Casper Webers
The 2022 ASAS-EULAR recommendations for the management of axial spondyloarthritis (axSpA) propose to consider dose reduction of biological disease-modifying antirheumatic drugs (bDMARDs) for patients in sustained remission. However, this recommendation does not offer clear guidance for daily clinical practice. In this review, we analyze randomized clinical trials and real-world data on tapering and discontinuation of bDMARDs in patients with axSpA. We discuss the scientific rationale and benefits of tapering, identify advice to apply tapering in current practice, and delineate aspects to be investigated in future research...
August 30, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37658016/diagnostic-delay-in-axial-spondylarthritis-a-lost-battle
#25
REVIEW
Rosemarie Barnett, Karl Gaffney, Raj Sengupta
Diagnostic delay in axial spondylarthritis (axSpA) remains an unacceptable worldwide problem; with evidence suggesting significant detrimental impact both clinically on the individual, and economically on society. There is therefore, a need for global action across various healthcare professions that come into contact with patients living, and suffering, with undiagnosed axSpA. Recent estimates of the median diagnostic delay suggest that globally, individuals with axSpA wait between 2 and 6 years for a diagnosis - revealing a clear benchmark for improvement...
August 30, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37652852/pregnancy-neonatal-outcomes-in-spondyloarthritis
#26
REVIEW
Sinead Maguire, Anna Molto
Limited research has been conducted on the impact of spondylitis (SpA) on fertility, but some studies suggest a higher risk of subfertility in women with SpA compared to the general population. Factors associated with impaired fertility in SpA include pain, fatigue, stiffness, functional disorders, depression, anxiety, negative body image, and the use of nonsteroidal anti-inflammatory drugs (NSAIDs) preconceptionally, while TNF alpha inhibitors may play a role in improving fertility in certain cases. There has been a recent increase in clinical research focused on pregnancy outcomes in SpA...
August 29, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37633827/the-burden-of-osteoarthritis-is-it-a-rising-problem
#27
REVIEW
William J Scheuing, Anthony M Reginato, Mery Deeb, Sevtap Acer Kasman
The objective of this review is to provide an overview of the current status of osteoarthritis (OA) as one of the most common joint disorders worldwide. Despite being the 11th cause of disability globally, there has been an increase in the prevalence, annual incidence, and years lived with disability of OA, particularly in developed and developing countries. Erosive hand OA, which affects approximately 10% of the general population, has been associated with a higher clinical burden compared to non-erosive hand OA...
August 24, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37633826/new-and-future-therapies-changes-in-the-therapeutic-armamentarium-for-sle
#28
REVIEW
Anca Askanase, Leila Khalili, Wei Tang, Philippe Mertz, Marc Scherlinger, Eden Sebbag, François Chasset, Renaud Felten, Laurent Arnaud
Following better understanding of molecular pathways involved in the pathogenesis of Systemic lupus erythematosus (SLE), pharmaceutical companies have been investigating new targeted drugs for SLE. The purpose of this scoping review is to provide an updated view of the most promising targeted therapies currently in clinical development or recently approved for SLE treatment as well as of the most promising potential future therapeutic strategies in SLE. In the past several years, two new drugs have been developed for lupus treatment along with an extended indication for belimumab...
August 24, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37625930/translational-implications-of-newly-characterized-pathogenic-pathways-in-systemic-lupus-erythematosus
#29
REVIEW
Mariele Gatto, Roberto Depascale, Ana Luisa Stefanski, Eva Schrezenmeier, Thomas Dörner
Improved characterization of relevant pathogenic pathways in systemic lupus erythematosus (SLE) has been further delineated over the last decades. This led to the development of targeted treatments including belimumab and anifrolumab, which recently became available in clinics. Therapeutic targets in SLE encompass interferon (IFN) signaling, B-T costimulation including immune checkpoints, and increasing modalities of B lineage targeting, such as chimeric antigen receptor (CAR) T cells directed against CD19 or sequential anti-B cell targeting...
August 23, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37620236/biomarkers-for-osteoarthritis-current-status-and-future-prospects
#30
REVIEW
Ali Mobasheri, Christian S Thudium, Anne-Christine Bay-Jensen, Tazio Maleitzke, Sven Geissler, Georg N Duda, Tobias Winkler
Osteoarthritis (OA) is the most common form of arthritis globally and a major cause of pain, physical disability, and loss of economic productivity, with currently no causal treatment available. This review article focuses on current research on OA biomarkers and the potential for using biomarkers in future clinical practice and clinical trials of investigational drugs. We discuss how biomarkers, specifically soluble ones, have a long path to go before reaching clinical standards of care. We also discuss how biomarkers can help in phenotyping and subtyping to achieve enhanced stratification and move toward better-designed clinical trials...
August 22, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37620235/musculoskeletal-manifestations-of-systemic-lupus-erythematosus
#31
REVIEW
Anastasiia Shumilova, Edward M Vital
MSK is the most common and impactful symptom of lupus at a population level. It has a variety of different presentations, but joint swelling is often not present despite imaging-proven synovitis. Imaging with US and MRI has been shown to improve detection of inflammation and identify treatment-responsive patients. In contrast, the SLEDAI shows poor sensitivity, specificity, and responsiveness. While BILAG and SLE-DAS are superior, they are still less accurate than imaging. These issues may explain why the evidence for conventional and biologic therapies for MSK lupus is complex...
August 22, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37599204/peripheral-spondyloarthritis-what-have-we-learned
#32
REVIEW
María Ángeles Puche-Larrubia, Clementina López-Medina, Nelly Ziadé
The peripheral spondyloarthritis (pSpA) entity remains poorly defined in comparison with axial SpA and psoriatic arthritis, as the clinical symptoms have low specificity, the biological markers are virtually lacking, and dedicated randomized controlled trials in this specific indication remain scarce. In addition, clinical similarities between pSpA and psoriatic arthritis (PsA) have been described, partly explained by a resemblance in the pathophysiology of both entities. Thus, diagnosing pSpA can be challenging because of the overlap with other entities and the absence of a specific test or imaging study that can definitively diagnose the condition...
August 18, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37596173/pregnancy-in-systemic-lupus-erythematosus
#33
REVIEW
Dina Zucchi, Rebecca Fischer-Betz, Chiara Tani
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease which frequently affects women of childbearing age. Nowadays, pregnancy is not contraindicated in cases of well-controlled disease activity, but pregnancies are still at higher risk of maternal and fetal complications compared to the general population. During pregnancy and puerperium patients are at risk of disease flare, and obstetric complications are more frequent in cases of active disease at conception/beginning of pregnancy, a history of lupus nephritis, and concomitant presence of antiphospholipid syndrome...
August 16, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37580227/vasculitis-in-the-20th-century-from-prayers-to-progress
#34
EDITORIAL
Tanaz A Kermani, Aman Sharma
No abstract text is available yet for this article.
August 12, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37574370/preface-to-practical-procedures-how-to-do
#35
EDITORIAL
Kenneth S O'Rourke, Mitsumasa Kishimoto
No abstract text is available yet for this article.
August 11, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37541813/the-association-between-comorbidities-and-disease-activity-in-spondyloarthritis-a-narrative-review
#36
REVIEW
Philipp Bosch, Sizheng Steven Zhao, Elena Nikiphorou
Comorbidities, including cardiovascular disease, osteoporosis, and depression, are more prevalent in patients with spondyloarthritis (SpA) than in the general population. Clinical and laboratory markers of disease activity are associated with numerous of these comorbidities, and studies suggest that the treatment of SpA can have a positive impact on comorbidities; conversely, managing comorbidities can improve disease activity. Therefore, the screening of comorbidities is considered a core component of a rheumatology consultation, and treatment should be performed in liaison with other health professionals (e...
August 2, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37524622/clinical-aspects-and-outcomes-in-osteoarthritis
#37
REVIEW
Mehmet Tuncay Duruöz, Nuran Öz, Didem Erdem Gürsoy, Halise Hande Gezer
Osteoarthritis (OA) is the most prevalent type of arthritis worldwide, and its incidence significantly increases with age. It commonly affects the knees, hips, spine, big toes, and hands. OA can be identified through clinical examination, symptoms, and imaging methods. Its main symptoms include pain, stiffness, and limitations in joint movement. Examinations may reveal coarse crepitus, bony enlargement, and tenderness at the joint line. In severe cases of OA, rest pain, night pain, and deformity may occur. OA can lead to decreased physical activity, function, and quality of life due to symptoms such as pain and stiffness...
July 29, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37516606/advanced-molecular-imaging-in-large-vessel-vasculitis-adopting-fdg-pet-into-a-clinical-workflow
#38
REVIEW
Mark A Ahlman, Peter C Grayson
The use of fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging to detect vascular inflammation is increasingly common in the clinical management of patients with large-vessel vasculitis (LVV). In this review, the role of FDG-PET imaging to diagnose and monitor vascular disease activity will be detailed. Suggestions on incorporation of FDG-PET imaging into a clinical workflow will be provided with emphasis on patient preparation, image acquisition, and image interpretation. If FDG-PET imaging is obtained, multimodal imaging assessment, whereby FDG-PET imaging and non-invasive angiography are obtained concurrently, and correlation of imaging findings with clinical assessment is generally advisable...
July 27, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37507281/arthrocentesis-and-soft-tissue-aspiration-and-injection
#39
REVIEW
Michael Toprover, Nicole Leung, Michael H Pillinger
Accessing a joint with a needle (arthrocentesis) to extract synovial fluid is a skill intrinsic to the rheumatologist's praxis. Joint aspirations are essential for diagnosing or excluding septic joints, are the gold standard for diagnosing acute crystal arthritis, and can provide valuable information about the nature of other forms of arthritis. In appropriate settings, injecting medications into joints can provide rapid, temporary, or even prolonged relief of pain and swelling and can provide a window of relief until other treatment modalities (anti-inflammatories, immunomodulators, and physical therapy) can enforce durable responses...
July 26, 2023: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/37481369/seeing-is-believing-smart-use-of-musculoskeletal-ultrasound-in-rheumatology-practice
#40
REVIEW
Sahil Koppikar, Pamela Diaz, Gurjit S Kaeley, Lihi Eder
Musculoskeletal ultrasonography has become an increasingly valuable tool as a complement to the physical exam in rheumatology practice. Its point-of-care access, low cost, safety, portability, and reliability in trained hands, make this technique especially useful in patients with inflammatory arthritis. Growing evidence has demonstrated the value of musculoskeletal ultrasound in the detection of inflammatory and structural changes in patients with joint pain without obvious joint swelling, in differentiating various inflammatory diagnoses, in the monitoring of inflammatory arthritis, and interventional procedures...
July 20, 2023: Best Practice & Research. Clinical Rheumatology
journal
journal
39746
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.